ICLR 176.36 ▼ -2.03% Live Trading Data - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    ICON Public Limited

    NASDAQ: ICLR · Real-Time Price · USD
    176.36
    -3.65 (-2.03%)
    At close: Sep 04, 2025, 3:59 PM
    174.51
    -1.05%
    Pre-market: Sep 05, 2025, 09:11 AM EDT
    -2.03%
    Bid 167
    Market Cap 13.72B
    Revenue (ttm) 8.09B
    Net Income (ttm) 794.25M
    EPS (ttm) 9.71
    PE Ratio (ttm) 18.16
    Forward PE 12.69
    Analyst Buy
    Ask 180
    Volume 2,066,012
    Avg. Volume (20D) 1,282,770
    Open 165.86
    Previous Close 180.01
    Day's Range 161.01 - 177.35
    52-Week Range 125.10 - 313.51
    Beta 1.17

    About ICLR

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol ICLR
    Website n/a
    Full Company Profile

    Analyst Forecast

    According to 0 analyst ratings, the average rating for ICLR stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

    Stock Forecasts

    Next Earnings Release

    ICON Public Limited is scheduled to release its earnings on Oct 22, 2025, during market hours.
    Analysts project revenue of ... Unlock content with Pro Subscription
    1 day ago
    -2.03%
    ICON shares are trading lower after the company an... Unlock content with Pro Subscription
    1 week ago
    -2.32%
    Shares of vaccine companies are trading lower following a Daily Beast report suggesting that President Trump and Health and Human Services Robert F. Kennedy, Jr. will ban Covid-19 vaccines "within months." Also, a report suggested that a Covid-19 vaccine skeptic will lead the Covid-19 immunization task force.
    news image

    3 days ago · marketbeat.com

    3 Healthcare Pathbreakers With Long-Term Tailwinds

    In the world of healthcare stocks, a major innovation, new medical device, or successful drug treatment can cement a firm's position as a leader. Unfortunately, many firms chase after these goals and ...

    news image

    3 weeks ago · businesswire.com

    The ICON Is Yours: Introducing the All-New Class of FC 26 ICONs

    REDWOOD CITY, Calif.--(BUSINESS WIRE)--Today, Electronic Arts Inc. (NASDAQ: EA) unveiled the official incoming class of EA SPORTS FC 26 ICONs, featuring the most fan-requested ICONs to-date. This year...

    news image

    1 month ago · seekingalpha.com

    ICON Public Limited Company (ICLR) Q2 2025 Earnings Call Transcript

    ICON Public Limited Company (NASDAQ:ICLR ) Q2 2025 Earnings Conference Call July 24, 2025 8:00 AM ET Company Participants Barry Balfe - Chief Operating Officer Kate Haven - Vice President of Investor ...

    news image

    1 month ago · seekingalpha.com

    ICON: Lower Guidance Downside And Expanded Repurchase Plan

    ICON may be relatively undervalued, trading at a ~10% discount to IQVIA and offering an attractive ~7% free cash flow yield that markets seem to be responding to now. The CRO sector faces near-term he...

    news image

    1 month ago · zacks.com

    Icon PLC (ICLR) Q2 Earnings and Revenues Top Estimates

    Icon PLC (ICLR) came out with quarterly earnings of $3.26 per share, beating the Zacks Consensus Estimate of $3.18 per share. This compares to earnings of $3.75 per share a year ago.

    news image

    1 month ago · businesswire.com

    ICON Announces Results of Annual General Meeting

    DUBLIN--(BUSINESS WIRE)--ICON Announces Results of Annual General Meeting.

    news image

    1 month ago · businesswire.com

    ICON Reports Second Quarter 2025 Results

    DUBLIN--(BUSINESS WIRE)--ICON Reports Second Quarter 2025 Results.

    news image

    1 month ago · zacks.com

    Analysts Estimate Icon PLC (ICLR) to Report a Decline in Earnings: What to Look Out for

    Icon PLC (ICLR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

    news image

    1 month ago · businesswire.com

    ICON's Leadership and Performance in Phase 1 Clinical Trials Recognised in Independent Industry Benchmarking Report

    DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been rated as one of the top-performing contract research organisation...

    news image

    1 month ago · fool.com

    LVM Capital Management Dumps 16,000 ICON Public Shares Worth $2.6 million

    According to an SEC filing dated July 2, 2025, LVM Capital Management reduced its position in ICON Public Limited (ICLR 0.92%) by selling 16,096 shares. The transaction was valued at $2.58 million.

    Add to Watchlist